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Abstract
The aryl hydrocarbon receptor nuclear translocator (ARNT) and cathepsin K (CTSK)
genes lie in a tandem head-to-tail arrangement on human chromosome 1. The two
genes are in extremely close proximity; the usual CTSK transcription start site is
less than 1.4 kb downstream of the end of the longest reported ARNT transcript.
By generating an RT-PCR product that overlaps both the 3 end of ARNT and
the 5 end of CTSK, we show that ARNT transcripts may extend through the
ARNT–CTSK intergenic region and progress into the CTSK gene. Furthermore,
by using quantitative RT-PCR from several tissues to detect the ARNT expression
signature in CTSK introns, we show that ARNT transcripts can read through into
CTSK as far as CTSK intron 3, extending approximately 3.7 kb downstream of the
end of the longest previously described ARNT mRNA. Given that ARNT and CTSK
are expressed in an overlapping range of tissues, ARNT read-through may have a
negative impact on CTSK transcript levels by interfering with CTSK expression.
We also present evidence for novel CTSK transcripts following sequence analysis
of CTSK-derived ESTs and RT-PCR products. These transcripts show alternate 5
splicing and or 5 extension and are sometimes initiated from a cryptic alternative
promoter which is upstream of the known CTSK promoter and possibly in the 3
UTR of ARNT. Copyright  2005 John Wiley & Sons, Ltd.
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Introduction
Cathepsin K (CTSK) is a cysteine protease of
the papain family. Substrates include type I col-
lagen and osteonectin, major components of the
organic matrix of bone (Bossard et al., 1996;
Bromme et al., 1996) suggesting that CTSK plays
a critical role in osteoclast-mediated bone degra-
dation. Although the predominant site of expres-
sion appears to be the osteoclast, consistent with
a role for CTSK in bone remodelling, CTSK
transcripts have also been detected in a range
of other tissues (Bromme and Okamoto, 1995;
Inaoka et al., 1995; Drake et al., 1996). The gene
encoding CTSK consists of eight exons spread
over approximately 12 kb on chromosome 1 (Rood
et al., 1997). The structure of the gene is unre-
markable, but it is in very close proximity to the
neighbouring upstream gene, the aryl hydrocar-
bon receptor nuclear translocator (ARNT) gene; the
accepted CTSK transcription start site is less than
1.4 kb downstream of the end of the ARNT tran-
script reference sequence (UCSC genome browser;
http://genome.ucsc.edu/). The ARNT gene has
22 exons spanning 65 kb (Scheel and Schrenk,
2000). The gene product, ARNT, is a basic
helix–loop–helix protein that complexes with the
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aryl hydrocarbon receptor (AHR) or one of a num-
ber of other protein partners to form transcrip-
tion factors involved in the activation of genes in
several biological pathways, including xenobiotic
response, neurogenesis, angiogenesis and response
to hypoxia (Swanson, 2002). ARNT is expressed in
a wide range of tissues (Carter et al., 1994), many
of which also express CTSK.
Given the extremely close proximity of the
two genes, highly efﬁcient termination of ARNT
transcription would be required to prevent occa-
sional read-through into CTSK. Although described
for yeast (Greger and Proudfoot, 1998), where
a compact genome places many genes close to
their neighbours, observation of transcription read-
through into an adjacent downstream gene in a
mammalian genome is extremely rare. Transcrip-
tion read-through has implications for the regu-
lation of gene expression; studies using plasmid
constructs in cell-based assay systems have shown
that read-through can interfere with expression of
the downstream gene, resulting in reduced tran-
script levels (Proudfoot, 1986; Henderson et al.,
1989; Greger and Proudfoot, 1998). Using RT-
PCR, we show that ARNT transcripts can indeed
read through into CTSK, extending beyond CTSK
exon 3. We also present evidence for novel CTSK
transcripts, some of which are initiated from a cryp-
tic alternative promoter, possibly residing in the 3 
UTR of ARNT.
Methods
EST identiﬁcation
ESTs were identiﬁed by querying the GenBank
human EST database with CTSK introns and
the ARNT–CTSK intergenic region, using the
BLAST (Altschul et al., 1990) server hosted at
the National Center for Biotechnology Information
(NCBI:http://www.ncbi.nlm.nih.gov/BLAST),
using the default software settings.
DNA sequencing
Following template preparation using standard
methods, EST clones (AA361613, BI826433 and
BM722737) and PCR products were sequenced
using a Big Dye Terminator Kit (Applied Biosys-
tems, Foster City, CA) and an Applied Biosystems
3700 or 3100 PRISM sequencing system in accor-
dance with the manufacturer’s instructions.
cDNA preparation
cDNA was prepared as described in Chapman
et al. (2000). Brieﬂy, human tissue or RNA was
purchased (Biochain, San Leandro, CA; Invitro-
gen, Leek, The Netherlands; Clontech, Palo Alto,
CA) or donated (Netherlands Brain Bank, Amster-
dam, The Netherlands) and poly A+ RNA prepared
from 10 tissue types (brain, heart, lung, liver, kid-
ney, skeletal muscle, intestine, spleen/lymphocyte,
placenta and testis) by the PolyATract method
(Promega, Madison, WI) in accordance with the
kit supplier’s instructions. Poly A+ RNA sam-
ples were quantitated using OD260nm measurement
or the RiboGreen ﬂuorescent method (Molecular
Probes, Eugene, OR) and 1 µg each RNA was
reverse-transcribed using random nonamers and
Superscript II reverse transcriptase (Invitrogen, San
Diego, CA) according to the supplier’s instruc-
tions. The cDNA prepared was diluted and arrayed
to produce replica 96-well plates using a Biomek
robot (Beckman Coulter, High Wycombe, UK),
such that each of the wells contained the cDNA
produced from 1 ng RNA for the appropriate tis-
sue. Plates were stored at −80 ◦C prior to use.
SYBR Green RT-PCR
SYBR green quantitative RT-PCR (Applied Biosys-
tems) was performed in accordance with kit sup-
plier’s guidelines, using cDNA templates prepared
as above. PCR reactions were performed in 1×
SYBR green PCR master mix with 400 nM each
gene-speciﬁc primer (Table 1) and 1 ng template.
Following initial incubations at 50 ◦Cf o r2m i n
and 95 ◦C for 10 min, samples were subjected to
40 cycles of PCR (95 ◦Cf o r1 m i n ,5 0 ◦Cf o r
1m i n ,5 9 ◦C for 1 min), using an ABI PRISM 7700
thermal cycler and signal detection instrument. In
addition to the sequences under study, three house-
keeping genes were measured (β-actin, GAPDH
and cyclophilin) to check RNA quality and quan-
tity.
PCR from cDNA
cDNA samples from ﬁve different tissues, heart,
skeletal muscle, macrophage, adipose and bone,
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Table 1. PCR primers
Region Primer pair
ARNT 3  UTR TCTTGATTGCGGCTTTATCATTC TGGAGCTTAAACTATAGATTCCTCTGG
Intergenic (ESTAA361613) AGTTGTCATTACTTCCAGGCAGAAT TCAGCAAAACCACATTAGGCTGGGAAAA
CTSK exon 2 GCTCAAGGTTCTGCTGCTACCT CTCCCAGTGGGTGTCCAGTATC
CTSK intron 1 AGTCCTTGGAACCAGATGTACCA TGAGGAAGAGAAAGGTAGACGGA
CTSK intron 3 GCAAGTATAGCTTCAGCTCCTGTC AGGGAACTAAAGCAAATGGTGC
CTSK intron 4 CACATAGCTACTGGGTGGCAAAG GGCATTTGTCCTGGGAGCTA
CTSK intron 6 TGCAGTATGGAGCAGCATCTCT CCCAGTCTAGGAGACTGTTTGAAGA
CTSK intron 7 CCCAGGTCCAAGCACTTACC TCCTCCCAGCTCTCTTGGAA
β-Actin GAGCTACGAGCTGCCTGACG GTAGTTTCGTGGATGCCACAGGA
GAPDH CAAGGTCATCCATGACAACTTTG ACCACAGTCCATGCCATCACTGCCA
Cyclophilin CATCTGCACTGCCAAGACTGA CCAAACACCACATGCTTGCCATCCA
Intragenic → exon 2 TCTGGGCATATCCTCCTTCA GTGGGTGTCCAGTATCTCCT
Intron 1 → exon 3 AGAATGAGGAGATATACAATGT CCCCCAGGTGGTTCATAGC
ARNT 3  UTR → CTSK exon 1 GAGAGAGGGGAAGAGTCGGGA CTGCTGATGGAAATCTGTTGTCT
The ﬁrst 11 primer pairs listed were used for SYBR green quantitative PCR. The three remaining pairs were used for ampliﬁcation of novel
CTSK 5  splice variants (‘intragenic → exon 2’ and ‘intron 1 → exon 3’) and an ARNT–CTSK overlapping transcript (‘ARNT 3  UTR → CTSK
exon 1’) from cDNA.
prepared as described above, were used. 40 pg
polyA cDNA were ampliﬁed in a total volume
of 20 µl with a concentration of 1 µM for each
primer, 1 mM dNTPs, 2 µl1 0 × buffer (Qiagen,
The Netherlands), 4 µl buffer Q (Qiagen) and 0.5
U Hot-start Taq Polymerase (Qiagen). PCR was
performed using a Peltier thermal cycler (Model
PTC-225) using the following parameters: a dena-
turing step at 94 ◦C for 10 min, followed by 40
cycles as follows: 94 ◦C for 1 min, an annealing
step at 58.4 ◦Cf o r1m i n ,7 2◦C for 3 min, followed
by a ﬁnal extension at 72 ◦C for 10 min. Primer
sequences are given in Table 1. PCR products were
separated by agarose gel electrophoresis and puri-
ﬁed using a gel extraction kit (Qiagen) prior to
sequencing as described above.
Test for correlation between expression levels
The Pearson correlation coefﬁcient for each pair-
wise comparison of expression levels for different
genomic regions was calculated using the COR-
REL function in Microsoft Excel. The test statistic
(t) was calculated using the formula:
t = r

n − 2
1 − r2
where r = correlation coefﬁcient and n = number
of tissues analysed. p-Values were calculated using
the TDIST function in Microsoft Excel (one-tailed
test).
Results
Novel CTSK 5  splicing and 5  extended CTSK
transcripts
The UCSC ‘Golden Path’ Genome Browser (http
://genome.ucsc.edu/) places the transcription start
site of the CTSK gene, as deﬁned by the CTSK ref-
erence sequence NM000396 (Li et al., 2004), less
than 1.4 kb downstream of the 3  end of the ARNT
gene, as deﬁned by the ARNT reference tran-
script NM 001668 (Chapman-Smith et al., 2004).
This is similar to the arrangement in the mouse
genome, where a 4.5 kb stretch of DNA separates
the Arnt and Ctsk transcripts (Rantakokko et al.,
1999). A BLAST search of the NCBI human EST
database (http://www.ncbi.nlm.nih.gov/BLAST/),
using the ARNT–CTSK intergenic sequence as a
query sequence, returned numerous ESTs with per-
fect or near-perfect matches. We also identiﬁed
several ESTs in CTSK introns 1, 2 and 3, some
of which bridge the exon–intron boundaries, sug-
gesting that these intergenic and intronic regions
show signiﬁcant levels of expression in a number
of tissue types (Figure 1). By contrast, very few
ESTs were retrieved by querying the database with
the remaining ﬁve CTSK introns (other than those
matching Alu repeats in introns 4 and 5 and a MER
repeat in intron 7, not shown).
In order to characterize the putative intergenic
and CTSK 5  intron transcripts further, three
ESTs were selected for further sequencing, two
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Figure 1. The CTSK gene and associated novel transcripts. Exons are represented by black bars and are numbered.
The position of the translation start site in exon 2 is shown by an arrow labelled ATG. The palegrey box immediately
upstream of exon 1 marked P represents the promoter described by Motyckova et al. (2001). The grey box upstream of
CTSK marked ARNT represents the ﬁnal exon of the ARNT gene. ESTs identiﬁed from querying the GenBank human EST
database are depicted as black lines above the 5  end of the CTSK gene; those selected for further sequencing are named
AA36163, BM22737 and BI826433. Novel cDNA sequences identiﬁed by EST sequencing and RT-PCR are shown below
the CTSK gene; solid black lines represent mRNA and faint dotted lines correspond to regions that are spliced out. Splice
form (i) corresponds to clone BI826433; the novel splicing pattern at the 5  end of this variant was conﬁrmed by PCR
from macrophage (M) cDNA. Splice form (ii) was identiﬁed by PCR from adipose (A) cDNA. Splice form (iii) corresponds
to clones AA361613 and BM722737 and was conﬁrmed by PCR from adipose (A), bone (B), heart (H) and skeletal muscle
(S) cDNA. Splice form (iv) was identiﬁed by PCR from macrophage (M) cDNA. Although not demonstrated empirically,
it seems likely that splice forms (i), (ii) and (iv), like splice form (iii), can form part of full-length CTSK transcripts. The
line with an arrowhead at each end, below the ARNT–CTSK intergenic region, shows the location of an RT-PCR product
representing an ARNT–CTSK overlapping transcript generated from heart, skeletal muscle, adipose and bone tissue. The
sequences of novel splice forms (i)–(iv) are shown in Supplementary Figure 1
from the intergenic ARNT–CTSK region (Gen-
Bank AA361613 and BM722737, derived from
T-lymphocyte and fetal eye, respectively) and one
from CTSK intron 1 (GenBank BI826433, derived
from medulla). Sequence analysis of the clones
represented by these ESTs revealed that clone
BI826433 is a partial CTSK cDNA extending
from what appears to be an alternative ﬁrst exon
located within intron 1. The novel exon 1 is cor-
rectly spliced to exon 2 and the clone extends as
far as exon 5, with exons 2–5 correctly spliced
(Figure 1). Using primers extending from EST
BI826433 to CTSK exon 3, we were able to PCR
amplify this splice form from macrophage cDNA,
providing evidence that this is a genuine transcript
rather than an artefact (Figure 2A). We identiﬁed
a second alternative splice form in cDNA from
adipose tissue, extending unspliced from within
intron 1 to exon 2, but with exon 2 correctly
spliced to exon 3 (Figures 1, 2A). As the CTSK
ATG translation start signal is in exon 2, it is pos-
sible for transcripts that are missing exon 1 or
have an alternative ﬁrst exon to encode a com-
plete CTSK protein with the correct amino acid
sequence.
ESTs AA361613 and BM722737, which map
to the ARNT–CTSK intergenic region, both rep-
resent full-length conventionally spliced CTSK
cDNA clones which extend the 5  end of the
CTSK transcript relative to the CTSK reference
sequence NM000396 (Figure 1); clone AA36163,
the longer of the two, extends the CTSK mRNA
by 722 bases. As with clone BI826433, we
were able to conﬁrm that these clones represent
genuine transcripts by PCR ampliﬁcation of 5 
extended transcripts with correct intron 1 splic-
ing from cDNA samples from a range of tissues
(Figure 2B). We observed an alternative transcript
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(A) CTSK intron 1 to exon 3
(B) Intragenic to CTSK exon 2
(C) ARNT 3’UTR to CTSK exon 1
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Figure 2. RT-PCR products from the ARNT–CTSK locus
(see Table 1 for primer sequences). (A) RT-PCR products
ampliﬁed using primers from CTSK intron 1 and exon 3.
The 405 bp and 888 bp fragments from macrophage and
adipose respectively represent the 5  ends of novel splice
forms (i) and (ii) shown in Figure 1. The 888 bp product
also appears to be present in heart, but the band is faint.
No products were generated from bone and only a faint
unspliced product was generated from skeletal muscle. The
1330 bp unspliced genomic DNA product is shown for
comparison. (B) RT-PCR products ampliﬁed using primers
from the ARNT-CTSK intergenic region and CTSK exon
2. All tissues tested, with the exception of macrophage,
yield a 743 bp fragment corresponding to the 5  end of
novel splice form (iii) shown in Figure 1. Macrophage cDNA
gives a 361 bp fragment representing novel splice form (iv)
shown in Figure 1. The 2170 bp unspliced genomic DNA
product is shown for comparison (but is faint). (C) RT-PCR
products ampliﬁed using primers from ARNT 3  UTR and
CTSK exon 1. All tissues tested give an unspliced 1597
bp product consistent with read-through from ARNT into
CTSK. However, the predominant species from macrophage
is a 172 bp product where the entire intergenic region has
been spliced out, joining the ARNT 3U T Rt oCTSK exon 1.
The sequence of this product is shown in Supplementary
Figure 2. (The very small product faintly visible in all lanes,
but most obvious in bone, is thought to be a primer dimer)
in macrophage-derived cDNA, with a novel intron
upstream of exon 1 spliced out (Figures 1, 2B).
Signiﬁcantly, these 5  extended transcripts stretch
back across almost the entire length of the 903
bp CTSK promoter characterized by Motyckova
et al. (2001) and are presumably driven from
an alternative cryptic promoter element further
upstream.
ARNT read-through into CTSK
To gauge the relative expression level of the 5 
extended CTSK message, we compared SYBR
green quantitative RT-PCR proﬁles (Wittwer et al.,
1997) from the 5  extended (‘intergenic’) region
and CTSK exon 2 in a number of tissue types.
ARNT expression levels were also measured by
including the 3  UTR of ARNT in this analysis.
Expression of the intergenic region was detected
in all tissues tested, at widely varying levels
(Figure 3A).
Although there is some evidence for correla-
tion between the CTSK expression pattern and the
expression proﬁle of the intergenic region (the cor-
relation coefﬁcient, r2, is 0.38, giving a p-value of
0.03; Table 2), the correlation between the inter-
genic region and ARNT expression patterns is far
stronger (r2 = 0.82, p = 1 × 10−4; Table 2). This
led us to hypothesize that this region can form part
of either CTSK or ARNT messages, due to ARNT
read-through into the intergenic region in addition
to 5  extension of CTSK transcripts. It should be
noted there is no signiﬁcant correlation between the
conventional CTSK and ARNT expression patterns
(r2 = 0.23, p = 0.08; Table 2). Transcript overlap,
most likely to be due predominantly to ARNT read-
through into CTSK, was conﬁrmed by ampliﬁcation
of a 1.6 kb fragment extending from the 3  UTR
of ARNT to CTSK exon 1 from cDNA samples
derived from heart, skeletal muscle, macrophage,
adipose tissue and bone (Figures 1, 2C). The iden-
tity of this fragment was conﬁrmed by sequenc-
ing. Prior to reverse transcription, mRNA samples
were tested for the presence of genomic DNA by
PCR (not shown); no evidence for contaminating
DNA was found, supporting the supposition that
this unspliced fragment is derived from cDNA and
is not residual genomic DNA carried over into the
cDNA samples. Furthermore, we identiﬁed a 172
bp fragment from macrophage cDNA (Figure 2C),
where the entire intergenic region had been spliced
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Figure 3. Intergenic and intronic expression proﬁles indicating ARNT read-through into CTSK. (A) SYBR green quantitative
PCR expression proﬁles for ARNT 3  UTR, CTSK exon 2, the intergenic region and CTSK intron 3 from a range of tissues,
showing that the intergenic region and CTSK intron 3 are transcribed and that their transcription proﬁles have more
similarity to ARNT than to CTSK. Correlation of CTSK intron 3 (or the intergenic region) with ARNT is far higher than
with CTSK exon 2 (see Table 2), providing evidence for ARNT read-through into CTSK. (B) Expression levels at ostensible
non-coding regions of the CTSK locus. From the ARNT 3  UTR to CTSK intron 4 a steady decline in ARNT-like expression is
apparent. Expression levels for the 3  CTSK introns 4, 6 and 7 are negligible
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Table 2. Correlation between expression proﬁles for
ARNT, the intergenic region, CTSK exon 2 and CTSK intron
3
ARNT
3
UTR Intergenic
CTSK
exon
2
CTSK
intron
3
ARNT 3  UTR — r2 = 0.82 r2 = 0.23 r2 = 0.70
p = 1 × 10−4 p = 0.08 p = 0.001
Intergenic — — r2 = 0.38 r2 = 0.89
p = 0.03 p = 2.4 × 10−5
CTSK exon 2 — — — r2 = 0.49
p = 0.01
CTSK intron 3 — — — —
Transcript copy numbering total RNA was assessed by SYBR green
quantitative RT-PCR for each locus and pairwise comparisons of
expression levels made across 10 tissues (brain, heart, lung, liver,
kidney, muscle, intestine, spleen, placenta and testis). Corresponding
scatter plots are shown in Supplementary Figure S2. r2 = the square
of the Pearson correlation coefﬁcient. p-Values were calculated using
a one-tailed t-test.
out, fusing the ARNT 3  UTR with CTSK exon
1, using the same splice acceptor as the novel
macrophage transcript (iv) shown in Figure 1.
In order to determine the extent of any potential
ARNT read-through, we analysed CTSK introns 1,
3, 4, 6 and 7 and found evidence for transcrip-
tion. Although much lower than ARNT 3  UTR
expression levels, proﬁles derived from the CTSK
introns correlate strongly with those for ARNT,
supporting the view that these transcripts repre-
sent ARNT transcription read-through into CTSK
(Table 2, Figure 3). The expression proﬁles from
CTSK introns are highly correlated with expres-
sion of both the intergenic region and ARNT. For
example, correlation of CTSK intron 3 expression
with expression of the intergenic region gives an
r2 value of 0.89 and a p value of 2.4 × 10−5
(Table 2). Similarly, r2 = 0.70, p = 0.001 when
comparing CTSK intron 3 expression with ARNT
expression (Table 2). There is also some evidence
for weak correlation between the expression pro-
ﬁles of CTSK exon 2 and intron 3 (r2 = 0.49,
p = 0.01; Table 2), possibly due to the presence
of small amounts of unspliced, alternately spliced
or partially spliced RNA in the mRNA samples. To
ensure that the ARNT 3  UTR was giving a true rep-
resentation of ARNT gene expression, we also mea-
sured expression levels of ARNT coding sequence,
with the same outcome (not shown). The ARNT-
like expression proﬁle declines steadily through
introns 1–3 and becomes negligible in introns 4,
6 and 7 (Figure 3C), suggesting that read-through
can extend as far as CTSK intron 3, approximately
3.7 kb downstream of the end of the longest pre-
viously described ARNT mRNA (Chapman-Smith
et al., 2004).
Discussion
The signiﬁcance of the alternative CTSK transcripts
and 5  splice forms is unclear. CTSK is translated
as an inactive precursor (preprocathepsin K) com-
prising a 15 amino acid N-terminal secretion sig-
nal sequence followed by a 99 amino acid leader
sequence; the active form of CTSK is formed
by cleavage and removal of the leader sequence
(Bromme et al., 1996, Bossard et al., 1996). There-
fore, although splice forms 1 and 2 (Figure 1)
could potentially add further amino acids to the N-
terminus of CTSK, due to the presence of upstream
in-frame ATG codons (not shown), the production
of novel protein isoforms from these splice vari-
ants seems unlikely. Furthermore, no higher molec-
ular weight species corresponding to proteins of
increased length have been observed by Western
blotting (Rieman et al., 2001; Hou et al., 2002).
Although CTSK may be unaffected at the protein
level, the alternative 5  ends may confer increased
or decreased message stability compared to the
conventional splicing pattern. Alternatively these
splice forms may be of little functional conse-
quence and simply contribute a minor additional
component to overall CTSK transcript levels. The
longer transcripts (splice forms 3 and 4) appear
to be transcribed from an alternative promoter in
either the intergenic region immediately upstream
of the known CTSK promoter or possibly in the
3  UTR of ARNT. Given the poor efﬁciency of
this cryptic promoter (reﬂected in the low levels
of CTSK expression driven from it), it may not be
a bona ﬁde promoter per se, but rather a sequence
from which ‘leaky’ expression occurs due to low-
level recruitment of transcription factors.
The ARNT cDNA reference sequence
NM 001668 (Chapman-Smith et al., 2004) has
2.3 kb of 3  UTR extending to within 1.4 kb of
the transcription start site of CTSK (see UCSC
human genome browser). A large number of ESTs
mapping across the entire 2.3 kb of ARNT 3 
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UTR attest to the conclusion that the ARNT tran-
script frequently reaches such a length. How-
ever, shorter ARNT transcripts have also been
reported, with 3  UTR in the range 178–1929 bp
(GenBank references BC028362, AL834279 and
M69238), implying that termination of ARNT tran-
scription can occur at any one of a number of
places downstream of the coding sequence. Puta-
tive polyadenylation signals (AATAAA) lie 78 bp
and 726 bp downstream of the TAG termination
codon; these signals may be employed to gener-
ate the shorter splice forms, although no T-rich
downstream sequence element (DSE), which is also
required for efﬁcient polyadenylation (Chen et al.,
1995), is apparent for either. Transcription termi-
nation is dependent on a functional polyadenyla-
tion signal (see Proudfoot, 2002) and the exis-
tence of transcripts with extensive 3  UTR suggests
that the ARNT AATAAA motifs act as weak sig-
nals, often failing to trigger termination and allow-
ing transcript formation to continue. No consensus
polyadenylation signals are apparent at the 3  end
of the longer transcripts, suggesting that termina-
tion of transcription is likely to be highly inefﬁcient
for these already extended messages, leading to
transcription read-through into the adjacent CTSK
gene. We cannot exclude the formal possibility that
the 1.6 kb transcript fragment that we identiﬁed,
extending from the 3  UTR of ARNT to CTSK exon
1, together with the 172 bp spliced form identi-
ﬁed from macrophage cDNA, represent 5  extended
CTSK transcripts driven from a cryptic promoter
within the ARNT gene. However, the identiﬁcation
of the ARNT expression signature in the intergenic
region and in 5  CTSK introns strongly suggests
that transcription read-through from ARNT into
CTSK is the more likely explanation.
There are other examples of overlapping tran-
scripts in the human and mouse genomes, although
the majority described to date are overlaps at the
3  end of genes in tail-to-tail orientation (see e.g.
Williams and Fried, 1986, Campbell et al., 1997;
Dear et al., 2000). Several examples of overlapping
gene groups, where exons of one gene are con-
tained within the introns of another, have also been
described (Karlin et al., 2002). However, to our
knowledge examples of transcription read-through
as described in this paper have not been reported
previously for mammalian genomes. Like ARNT
and CTSK, the Rab geranylgeranyl transferase α-
subunit gene (RABGGTA) and transglutaminase 1
gene (TGM1) are arranged in tandem orientation
with less than 2 kb separating the 3  end of RABG-
GTA from the transcription initiation site of TGM1.
Putative regulatory elements that inﬂuence TGM1
expression are found in the 3  end of the RABGGTA
transcribed region (Van Bokhoven et al., 1996),
although at present there is no evidence for RABG-
GTA transcription read-through into the TGM1
coding sequence.
Studies with yeast and cell-based mammalian
assay systems have shown that transcription read-
through can reduce expression of the adjacent
downstream gene (Proudfoot, 1986; Henderson
et al., 1989; Greger and Proudfoot, 1998). Given
that ARNT and CTSK are co-expressed in a number
of tissues (Figure 3), it is possible that ARNT read-
through has a negative impact on CTSK expression.
Although rarely reported to date, transcription read-
through into a nearby gene, particularly at low
levels, may be a fairly common phenomenon
in the mammalian genome and, as postulated
several years ago (Proudfoot, 1986), could be an
important factor in the regulation of mammalian
gene expression. Functional studies will be required
to assess the molecular and physiological impact of
ARNT read-through into CTSK.
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